Anti-platelet-derived growth factor subunit B/anti-vascular endothelial growth factor benefits wet age-related macular degeneration

Recently released topline results from a phase Iib clinical trial of treatment for neovascular age-related macular degeneration show significantly greater improvement in visual acuity among patients receiving combination therapy with Fovista, an investigational aptamer directed against PDGF-B, plus anti-VEGF therapy compared with anti-VEGF therapy alone.

Full Story →